VEGFA and age-related macular degeneration: Macugen, an anti-vascular endothelial growth factor (VEGF) drug previously known as pegaptanib, was hailed as a revolutionary treatment for age-related macular degeneration (AMD), which had no other FDA-approved treatment at that time.